Thus even at a larger subset of Breast cancer patient samples, we do find a possible correlation of miR-29a and PC4 expression validating miR29a as a negative regulator of PC4 expression and mediating its downregulation in Breast cancer patient samples. The gene discussed is SUB1; the disease is breast cancer.